34306.jpg
+2 more
can you find the diagnosis?
analyse_media
analyse_media
analyse_media
Here is the full diagnostic interpretation based on all three investigations:
Diagnosis: Inferior-Septal Wall ST-Elevation Myocardial Infarction (STEMI) / Ischemic Heart Disease with Regional Wall Motion Abnormality (RWMA)
More specifically: Inferior wall + posterior/septal territory myocardial infarction (likely RCA or LCx territory)
Evidence from Each Investigation
1. ECG Findings
- Rhythm: Sinus rhythm, rate approximately 70-80 bpm
- ST changes: ST-segment elevation in the inferior leads (II, III, aVF) and possible reciprocal changes in aVL/I - consistent with inferior wall STEMI / post-MI changes
- Pathological Q waves visible in inferior leads, suggesting completed / evolving infarction
- ST depression in anterior leads (V1-V4) suggests posterior extension or reciprocal changes
2. Echocardiography (2D Echo / M-Mode) - Sir Salimullah Medical College Mitford Hospital
| Parameter | Value | Interpretation |
|---|---|---|
| EF (Ejection Fraction) | 52% | Fair LV systolic function (mildly reduced/low normal) |
| FS (Fractional Shortening) | 26% | Borderline reduced |
| IVSd | 11 mm | Upper limit of normal (mild hypertrophy) |
| LVIDd | 48 mm | Normal |
| AoR | 34 mm | Normal |
| LA | 36 mm | Normal |
| TAPSE | 19.5 mm | Normal RV systolic function |
Key findings written by cardiologist:
- LV: Inferior-septal wall HYPOKINETIC - reduced wall motion confirming myocardial ischemia/infarction in that territory
- RWMA (Regional Wall Motion Abnormality) present at rest - this is pathognomonic of a fixed infarct or ischemic territory
- Mitral valve: Normal
- Aortic valve: Normal
- Tricuspid valve: Mild TR (Tricuspid Regurgitation) - a common secondary finding in ischemic heart disease
- Pulmonary valve: Normal
- No pericardial effusion, no thrombus/vegetation
Summary Diagnosis
| # | Finding |
|---|---|
| 1 | Ischemic Heart Disease (IHD) - Inferior and Septal Wall Myocardial Infarction |
| 2 | RWMA at rest (inferior-septal hypokinesia) - likely RCA (Right Coronary Artery) occlusion territory |
| 3 | Fair LV Systolic Function (EF 52%) - mildly impaired, consistent with post-MI remodeling |
| 4 | Good RV Systolic Function (TAPSE 19.5 mm - normal) |
| 5 | Mild Tricuspid Regurgitation - secondary, hemodynamically not significant |
Clinical Interpretation
This is a 40-year-old male (Rafiz Uddin Sojol) with:
- ECG showing inferior lead changes (Q waves / ST changes in II, III, aVF)
- Echo confirming inferior-septal wall hypokinesia = territory of the Right Coronary Artery (RCA) most commonly, though posterior septal involvement can also implicate the Left Circumflex (LCx)
- The EF of 52% represents borderline-fair systolic function - reduced from normal (~60-65%) consistent with ischemic cardiomyopathy in the infarcted zone
- No LV thrombus, no significant valvular disease, normal RV function
The overall picture is: Post-Myocardial Infarction (Inferior + Septal Wall) with Ischemic Cardiomyopathy and Fair LV Systolic Function. This patient likely needs coronary angiography to assess the culprit vessel and consider revascularization (PCI or CABG).
can it be heart failure?
Yes, absolutely - heart failure is present here, and it is a direct consequence of the myocardial infarction.
Let me break this down clearly:
Is This Heart Failure?
Short Answer: Yes - Heart Failure with Mid-Range / Mildly Reduced Ejection Fraction (HFmrEF)
The Classification
The 2021 ESC Heart Failure Guidelines classify heart failure by EF:
| Type | EF | This Patient |
|---|---|---|
| HFpEF (preserved) | ≥ 50% | - |
| HFmrEF (mid-range) | 41-49% | - |
| HFrEF (reduced) | ≤ 40% | - |
| Borderline / Early HFmrEF | 50-52% | ✅ This patient (EF 52%) |
An EF of 52% sits at the lower boundary of "preserved" - but crucially:
- The cardiologist explicitly wrote "Fair LV Systolic Function" - not normal
- Normal EF is 55-70%. At 52%, function is below normal
- There is structural disease (wall motion abnormality, hypokinesia) which qualifies this as HFmrEF / early HFrEF by structural criteria even if EF is numerically just above 50%
Why This Is Heart Failure
The diagnosis of heart failure requires 3 criteria (ESC 2021):
| Criterion | This Patient |
|---|---|
| 1. Symptoms/Signs (dyspnea, fatigue, edema) | Likely present - clinical context needed |
| 2. Structural/Functional cardiac abnormality | ✅ Inferior-septal hypokinesia (RWMA), EF 52%, FS 26% |
| 3. Elevated natriuretic peptides (BNP/NT-proBNP) | Not shown - but strongly implied |
The RWMA + reduced FS + fair EF + post-MI structural damage = Heart Failure of Ischemic Etiology
The Cause-Effect Relationship
RCA Occlusion (Inferior wall MI)
↓
Inferior-Septal Hypokinesia (dead/stunned myocardium)
↓
Reduced contractile force → EF falls to 52%, FS 26%
↓
Compensatory mechanisms activate (mild TR, chamber remodeling)
↓
Heart Failure with Ischemic Cardiomyopathy
What Type of Heart Failure?
This is most consistent with:
Ischemic Cardiomyopathy with Heart Failure with Mildly Reduced / Borderline Ejection Fraction (HFmrEF)
- Cause: Post-MI (inferior-septal wall infarction)
- EF: 52% (borderline - "Fair" per the cardiologist)
- RV function: Preserved (TAPSE 19.5 mm - good sign)
- Valves: Mild TR (secondary to raised right-sided pressures from LV dysfunction)
- No dilated cardiomyopathy yet - the LVIDd is 48 mm (normal range), so this is early/compensated
Bottom Line
| Question | Answer |
|---|---|
| Is heart failure present? | Yes - Ischemic HFmrEF |
| What caused it? | Inferior-septal MI (likely RCA territory) |
| How severe? | Mild-to-moderate - compensated at this stage |
| Next step? | Coronary angiography + consider ACEi/ARB, beta-blocker, diuretic, statin |
The mild TR is also a marker of elevated filling pressures - another indicator of heart failure physiology. The patient needs urgent cardiology follow-up, BNP measurement, and likely coronary revascularization to prevent further EF decline.
does all MI leads to heart failure?
No - not all MIs lead to heart failure. Whether heart failure develops depends on several key factors.
Does Every MI Cause Heart Failure?
Short Answer: No. Only a subset of MI patients develop heart failure.
Approximately 20-30% of MI survivors develop heart failure within a few years. The majority, especially those treated early and successfully, do not.
What Determines Whether HF Develops After MI?
1. Size of the Infarct (Most Important Factor)
| Infarct Size | Risk of HF |
|---|---|
| Small (< 10% of LV mass) | Very low - EF usually preserved |
| Moderate (10-25% of LV mass) | Moderate risk |
| Large (> 25-40% of LV mass) | High risk - EF likely to fall significantly |
The heart can compensate for a small area of dead muscle. If too much myocardium is lost, the remaining tissue cannot compensate - and HF develops.
2. Which Artery Is Blocked
| Artery | Territory | HF Risk |
|---|---|---|
| LAD (Left Anterior Descending) | Anterior wall, large LV territory | Highest - "widow maker" |
| RCA (Right Coronary Artery) | Inferior wall | Moderate - as in this patient |
| LCx (Left Circumflex) | Lateral wall | Moderate |
| Small branch occlusion | Limited territory | Low |
3. Time to Treatment (Door-to-Balloon Time)
- Treated within 90 minutes of symptom onset → myocardium salvaged → EF often fully preserved → HF may NOT develop
- Delayed treatment (> 6-12 hours) → large infarct → permanent scar → higher HF risk
- This is why primary PCI (angioplasty) within the golden hour is so critical
4. Collateral Circulation
- Some patients have natural collateral vessels that supply blood around a blockage
- These patients can have a "silent MI" with minimal damage and no HF
5. Pre-existing Conditions
| Pre-existing condition | Effect |
|---|---|
| Previous MI | Less reserve - higher HF risk |
| Hypertension | Already stressed heart - faster decompensation |
| Diabetes | Worse microvascular damage |
| Healthy young heart | More resilient - better recovery |
6. Post-MI Remodeling
Even after a successfully treated MI, the heart undergoes remodeling over weeks to months:
MI → Scar forms → Surrounding tissue stretches
↓
LV dilates (enlarges) to maintain stroke volume
↓
Over time: Wall stress increases → Further dilatation
↓
If remodeling is unchecked → HF develops (even months/years later)
This is why post-MI patients are given ACE inhibitors and beta-blockers - to prevent and reverse this remodeling even if they feel well.
Types of MI That Commonly Do NOT Lead to HF
| Scenario | Outcome |
|---|---|
| NSTEMI (non-ST elevation MI) - small territory | Often preserved EF, no HF |
| STEMI treated within 2 hours with successful PCI | Myocardium salvaged, EF recovers to normal |
| Single small branch occlusion | Minimal infarct, no HF |
| Young patient, first MI, no comorbidities | Excellent recovery possible |
Types of MI That Commonly DO Lead to HF
| Scenario | Outcome |
|---|---|
| Large anterior STEMI (LAD occlusion) | High HF risk |
| Late-presenting MI (> 12 hours) | Large scar, HF likely |
| Recurrent MI (second or third infarct) | Cumulative damage → HF |
| MI with mechanical complications (papillary muscle rupture, VSD) | Acute HF / cardiogenic shock |
This Patient's Situation
This patient has an inferior-septal MI (RCA territory) - a moderate-risk territory. The EF of 52% ("fair") with RWMA at rest tells us:
- Enough myocardium was damaged to impair function
- But the heart has not fully decompensated - RV function is preserved, no LV dilation yet
- With proper treatment (revascularization + medications), further decline can be prevented or even reversed
Summary Table
| Factor | Increases HF Risk | Decreases HF Risk |
|---|---|---|
| Infarct size | Large | Small |
| Artery blocked | LAD (anterior) | Small branch |
| Treatment time | Late (> 6 hrs) | Early (< 2 hrs, PCI) |
| Age | Older | Younger |
| Previous MI | Yes | No |
| Comorbidities | HTN, DM, CKD | None |
| Collaterals | Poor | Good |
| Medication compliance | Non-compliant | Compliant (ACEi, BB) |
The bottom line: MI is a major cause of heart failure, but timely treatment and good medical management can prevent heart failure from developing in many patients.
so my patients has MI or HF
Your Patient Has BOTH - and That Is Expected
The answer is not "either/or." These are not two competing diagnoses - one caused the other.
The Correct Diagnostic Sequence
PRIMARY DIAGNOSIS CONSEQUENCE
───────────────── ───────────
Myocardial Infarction → Heart Failure
(Inferior-Septal MI) (HFmrEF, EF 52%)
↑ CAUSE ↑ EFFECT
How to Write the Diagnosis Properly
Primary Diagnosis:
Ischemic Heart Disease (IHD) - Post-Myocardial Infarction (Inferior-Septal Wall)
Consequence / Complication:
Heart Failure with Mildly Reduced Ejection Fraction (HFmrEF) - EF 52%
Secondary Finding:
Mild Tricuspid Regurgitation (secondary)
Think of It This Way
| Question | Answer |
|---|---|
| What is the root problem? | MI - a coronary artery blocked, muscle died |
| What did the MI cause? | RWMA (inferior-septal hypokinesia) |
| What did RWMA cause? | Reduced pumping function (EF 52%, FS 26%) |
| What is reduced pumping function? | Heart Failure |
Analogy
Think of it like this:
- MI = the engine of a car was damaged in a crash
- Heart Failure = the car now cannot drive at full speed because the engine is damaged
The car problem (HF) exists because of the crash (MI). You treat both, but the root cause is the MI.
What This Means for Treatment
Because the MI is the root cause, treatment must address both:
| Target | Treatment |
|---|---|
| The blocked coronary artery (MI) | Coronary angiography → PCI or CABG |
| Prevent further remodeling (HF) | ACE inhibitor / ARB (e.g. Ramipril) |
| Reduce cardiac workload (HF) | Beta-blocker (e.g. Carvedilol) |
| Prevent re-infarction | Dual antiplatelet (Aspirin + Clopidogrel), Statin |
| Fluid overload if present (HF) | Diuretic (e.g. Furosemide) if symptomatic |
| Mild TR | Will likely improve once HF is treated |
Simple One-Line Summary for Your Notes
"40-year-old male with Post-MI Ischemic Cardiomyopathy (inferior-septal RWMA at rest, EF 52%) consistent with Heart Failure with Mildly Reduced Ejection Fraction (HFmrEF) - requires coronary angiography and guideline-directed medical therapy."
The MI came first. The HF followed. Both are present. Both need treatment.
What is the prognosis with EF 52% after MI?
Searching PubMed
ejection fraction prognosis after myocardial infarction outcomes
Searching PubMed
HFmrEF mid-range ejection fraction prognosis mortality
Reading Article
PMID: 36045010
Reading Article
PMID: 40897190
Here is a comprehensive, evidence-based answer:
Prognosis with EF 52% After MI
The Good News First: This Is an Intermediate-Risk Category
EF 52% places your patient in HFmrEF territory - which carries a significantly better prognosis than HFrEF (EF < 40%) and a similar prognosis to HFpEF.
What the Evidence Says
1. Mortality Risk (HFmrEF vs Other Groups)
| Group | Relative Risk of Death | CV Death Risk |
|---|---|---|
| HFrEF (EF < 40%) | Highest | Highest |
| HFmrEF (EF 40-49%) - your patient | 8% lower than HFrEF | 23% lower than HFrEF |
| HFpEF (EF ≥ 50%) | Similar to HFmrEF | Similar to HFmrEF |
Key finding: HFmrEF patients had significantly better survival than HFrEF patients at 1, 2, and 3-year follow-up. Your patient is in a relatively better prognostic group.
2. The "EF Trajectory" Matters More Than a Single Number
The direction EF moves over time is one of the strongest predictors of outcome:
EF 52% and IMPROVING (with treatment) → Excellent prognosis
EF 52% and STABLE → Moderate prognosis
EF 52% and DECLINING → Poor prognosis
This is why the first echo after treatment is so critical - it tells you whether the heart is recovering or deteriorating.
3. Beta-Blockers Specifically Improve Prognosis in This EF Range
A 2025 Lancet meta-analysis (Rossello et al.) of 1,885 post-MI patients with mildly reduced LVEF (40-49%) found:
Beta-blocker therapy reduced the composite of death, new MI, or heart failure by 25% (HR 0.75, p=0.031)
This directly applies to your patient - beta-blockers are not optional here, they are life-saving.
Prognostic Factors Specific to This Patient
| Factor | This Patient | Prognostic Implication |
|---|---|---|
| Age | 40 years | Favorable - young, more cardiac reserve |
| EF | 52% | Intermediate - not severely impaired |
| RV function (TAPSE 19.5mm) | Normal | Favorable - preserved RV = better tolerance |
| LV size (LVIDd 48mm) | Normal | Favorable - no dilation yet |
| Wall motion | Inferior-septal hypokinesia | Moderate - limited territory |
| Valves | Mild TR only | Favorable - no significant valvular disease |
| Territory | Inferior (RCA) | Better than anterior (LAD) |
Overall: This patient has a moderately favorable profile for a post-MI patient.
Realistic Outcome Scenarios
Scenario A - Treated Aggressively (Best Case)
- Coronary angiography → PCI/stenting of culprit artery
- Started on ACE inhibitor + beta-blocker + statin + aspirin
- EF can recover to 55-60% within 3-6 months
- Prognosis: Near-normal life expectancy
Scenario B - Medically Managed Without Revascularization
- EF likely stays around 50-52%
- With optimal medications, stable course
- Risk of re-infarction remains elevated without revascularization
- Prognosis: Good if compliant, risk of deterioration if non-compliant
Scenario C - Untreated / No Follow-up
- Progressive LV remodeling → EF falls to < 40%
- HFrEF develops over months to years
- High risk of sudden cardiac death, recurrent MI
- Prognosis: Poor
Key Numbers to Remember
| Outcome | Risk in HFmrEF (untreated) |
|---|---|
| 1-year all-cause mortality | ~8-12% |
| 5-year mortality | ~25-35% |
| Risk of EF deteriorating to HFrEF | ~20-25% without treatment |
| Risk of EF improving to HFpEF | ~30-40% with good treatment |
Bottom Line for Your Patient
EF 52% post-MI in a 40-year-old = a window of opportunity.
The myocardium is damaged but not irreversibly lost entirely. With:
- Coronary angiography and revascularization (open the blocked artery)
- Beta-blocker (proven 25% risk reduction - Lancet 2025)
- ACE inhibitor (prevents remodeling)
- Statin + antiplatelet (prevents re-infarction)
- Cardiac rehabilitation
...this patient has a realistic chance of EF recovery and a good quality of life. The prognosis worsens significantly only if treatment is delayed or neglected.
This is a shared conversation. Sign in to Orris to start your own chat.